Anti cancer activity of rodent tuber (Thyphonium flagelliforme (lodd.) Blume on human breast cancer t47d cells

Authors

  • Arief Nurrochmad Department of Pharmacology and Clinical Pharmacy Faculty of Pharmacy, Gadjah Mada University Sekip Utara Yogyakarta INDONESIA 55281.
  • Endang Lukitaningsih Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Gadjah Mada University, Sekip Utara Yogyakarta 55281, Indonesia.
  • Edy Meiyanto Cancer Chemoprevention Research Center, Faculty of Pharmacy, Gadjah Mada University, Sekip Utara Yogyakarta 55281, Indonesia.

Keywords:

Rodent tuber (Thyphonium flagelliforme (Lodd.) Blume), anti cancer, chemoprevention, T47D cells

Abstract

The incidence of breast cancer in developing countries showed an increase from year to year. The efforts of cancer prevention or treatment of the more important given the frequency of occurrence is quite high. Several studies have been focuses on natural products as agents of cancer chemoprevention and as co-chemotherapy agent against cancer. One of medicinal plant that is widely used as anticancer is rodent tuber (Thyphonium flagelliforme (Lodd.) Blume). In present study, we investigated the anticancer acitivty of rodent tuber extract (RTE) in vitro. Study of anti-proliferative conducted on human breast cancer primary T47D cells. Furthermore, the present study also investigated the molecular mechanisms of cell cycle arrest and induction of apoptosis. The study of rodent tuber as co-chemotherapy is determined by examining the effects on T47D and its combination with tamoxifen (TAM). The results showed the cytotoxic effects of RTE on T47D cells with IC50 value of 632 μg/mL. Low concentration RTE (below 250 ug/mL) are proliferative, while the concentration above 250 μg/mL indicated cytotoxic effect. Based on the calculation of Combination Index (CI), combination of RTE with TAM yielded a value above 10 indicated a strong antagonistic effect. In observation of apoptosis, low concentration of RTE (63 µg/mL) stimulate apoptosis better than high concentration of 250 μg/mL. However, the combination study with 5 nM TAM reduced the induction of apoptosis. Furthermore, the observation cell cycle arrest by flowcytometry, demonstrated that RTE 63 and 250 μg/mL increase the population of sub G1 phase respectively from 14.8% to 53.19 and 32.90%. These results suggest that RTE able to induce cell cycle to apoptosis, but low concentration of RTE more effective than high concentration. Similar to apoptosis observation, the combination of RTE and TAM also demonstrated the antagonistic effect by reducing the population of Sub-G1 RTE (63 μg/mL) and TAM 5 nM, respectively from 53.19% and 44.50% to 35.86%. All finding results of this study provide information that the use of rodent tuber extract (RTE) alone is better than the combination with TAM. In addition, the use of RTE together with TAM reduced the effectiveness of TAM in the treatment of breast cancer.

References

Singletary K, MacDonald C, Lovinelli M,

Fisher C, Wallig M. Effect of the betadiketones diferuloylmethane (curcumin) and

dibenzoylmethane on rat mammary DNA

adducts and tumors induced by 7,12-

dimethylbenz[a]anthracene, Carcinogenesis.

;9(6):1039–1043.

Yaar M, Eller MS, Panova I, Kubera J, Wee

LH, Cowan KH, Gilchrest BA. Telomeric

DNA induces apoptosis and senescence of

human carcinoma cells, Breast Cancer

Research. 2007;9:R13.

Choo CY, Chan KL, Sam TW, Hitotsuyanagi

Y, Takeya K. The cytotoxicity and chemical

constituents of the hexane fraction of

Thyponium flagelliformae (Araceace). J

Ethnopharmacol. 2001;77:129–131.

Lai CS, Mas RH, Nair NK, Majid MI,

Mansor SM, Navaratnam V. Thyponium

flagelliformae inhibits cancer cell growth in

vitro and induced apoptosis: an evaluation by

the bioactivity guided approach. J.

Ethnopharmacol. 2008;118:14–20.

Peterson G, Barnes S. Genistein inhibition of

the growth of human breast cancer cells:

independence from estrogen receptors and the

multi-drug resistance gene. Biochem Biophys

Res Commun. 1991;179:661–667.

Pagliacci MC, Smacchia M, Migliorati G,

Grignani F, Riccardi C, Nicoletti I. Growthinhibitory effects of the natural phytoestrogen

genistein in MCF-7 human breast cancer

cells. Eur J Cancer. 1994;30A(11):1675–

Hsieh CY, Santell RC, Haslam SZ and

Helferich WG. Estrogenic effects of genistein

on the growth of estrogen receptor-positive

human breast cancer (MCF-7) cells in vitro

and in vivo. Cancer Res. 1998;58:3833–3838.

Shao ZM, Shen ZZ, Fontana JA, Barsky SH.

Genistein’s “ER-dependent and independent”

actions are mediated through ER pathways in

ER-positive breast carcinoma cell lines.

Anticancer Res. 2000;20:2409–2416.

Zava DT, Duwe G. Estrogenic and

antiproliferative properties of genistein and

other flavonoids in human breast cancer cells

in vitro. Nutr Cancer. 1997;27:31–40.

Fioravanti L, Cappelletti V, Miodini P,

Ronchi E, Brivio M, Di Fronzo G.

Genistein in the control of breast cancer

cell growth: insights into the mechanism of

action in vitro. Cancer Lett. 1998;130:143–

Cuzick J, Forbes J, Edwards R, Baum M,

Cawthorn S, Coates A, Hamed A, Howell

A, Powles T; IBIS investigators. First

results from the International Breast Cancer

Intervention Study (IBIS-I): A randomised

prevention trial. Lancet 2002;360:817–824.

Powles T, Eeles R, Ashley S, Easton D,

Chang J, Dowsett M, Tidy A, Viggers J,

Davey J. Interim analysis of the incidence

of breast cancer in the Royal Marsden

Hospital tamoxifen randomized

chemoprevention trial. Lancet.

;352:98–101.

Veronesi U, Maisonneuve P, Costa A,

Sacchini V, Maltoni C, Robertson C,

Rotmensz N, Boyle P. Prevention of breast

cancer with tamoxifen: Preliminary

findings from the Italian randomized trial

among hysterectomised women. Lancet.

;352:93–97.

Cuzick J, Powles T, Veronesi U, Forbes J,

Edwards R, Ashley S, Boyle P. Overview

of the main outcomes in breast-cancer

prevention trials. Lancet.2003;361:296–

Verma SP, Goldin BR, Lin PS. The

inhibition of the estrogenic effects of

pesticides and environmental chemicals by

curcumin and isoflavonoids, Environ

Health Perspect 1998;106:807–812.

Fisher B, Dignam J, Bryant J, DeCillis A,

Wickerham DL, Wolmark N, Costantino J,

Redmond C, Fisher ER, Bowman DM,

Deschênes L, Dimitrov NV, Margolese RG,

Robidoux A, Shibata H, Terz J, Paterson

AH, Feldman MI, Farrar W, Evans J,

Lickley HL. Five vs more than five years of

tamoxifen therapy for breast cancer patients

with negative lymph nodes and estrogen

receptorpositive tumors. J. Natl Cancer

Inst. 1996;88:1529–1542.

Fisher B, Costantino JP, Wickerham DL,

Redmond CK, Kavanah M, Cronin WM,

Vogel V, Robidoux A, Dimitrov N, Atkins J,

Daly M, Wieand S, Tan-Chiu E, Ford L,

Wolmark N. Tamoxifen for prevention of

breast cancer: report of the National Surgical

Adjuvant Breast and Bowel Project P-1 Study.

J Natl Cancer Inst 1998;90:1371–1388.

Downloads

Published

31-03-2011

How to Cite

1.
Arief Nurrochmad, Endang Lukitaningsih, Edy Meiyanto. Anti cancer activity of rodent tuber (Thyphonium flagelliforme (lodd.) Blume on human breast cancer t47d cells. ijp [Internet]. 2011 Mar. 31 [cited 2024 Dec. 3];3(1):138-46. Available from: https://ijp.arjournals.org/index.php/ijp/article/view/89

Issue

Section

Original Research Articles

Most read articles by the same author(s)